Wyeth Counterclaim Changes Direction Of Compass Price-Fixing Suit
This article was originally published in The Tan Sheet
Wyeth Consumer Healthcare says its decision to reduce commission for Compass Marketing was the result of the brokerage firm's failure to meet sales objectives, not collusion between Wyeth and Schering-Plough, according to a counterclaim filed in Maryland district court
You may also be interested in...
Schering-Plough and Wyeth are accused of fixing prices in distribution contracts involving the firms' OTC drugs in a lawsuit filed in Greenbelt, Md. federal court May 26
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Perrigo promotes in pricing, planning